Back to Journals » Clinical Ophthalmology » Volume 7

Improvement of visual acuity in diabetic and nondiabetic patients after Nd:YAG laser capsulotomy

Authors Awan MT, Khan MA, Al-Khairy S, Malik S

Received 2 July 2013

Accepted for publication 16 August 2013

Published 11 October 2013 Volume 2013:7 Pages 2011—2017


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Muhammed Tayyab Awan,1,2 Muhammed Anwar Khan,3 Saba Al-Khairy,1,4 Samina Malik1,4

1Pak Lab and Diagnostic Center, Karachi, Pakistan; 2School of Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland, UK; 3Department of Medical Education, King Saud bin Abdul-Aziz University of Health Sciences, Riyadh, Saudi Arabia; 4Department of Ophthalmology, Jinnah Post Graduate Medical Center, Karachi, Pakistan

Purpose: The aim of the study reported here was to compare the improvement of visual acuity (VA) of diabetic and nondiabetic patients after neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser capsulotomy.
Methods: In this prospective cohort study, 50 age- and sex-matched patients, comprising 25 nondiabetics and 25 diabetics (referred to as Group A and B, respectively), with posterior chamber poly(methyl methacrylate) non-foldable intraocular lens implants attending our clinic at Karachi for capsulotomy had pre- and postoperative measures of VA, posterior pole visibility, and grading of posterior capsular opacity as seen on slit-lamp examination. VA was recorded before and after performing standard capsulotomy.
Results: The postoperative (mean) VA in nondiabetics was 0.25, 0.23, and 0.21 logMAR as compared with 0.25, 0.25, and 0.24 logMAR in diabetics at 1 week, 1 month, and 6 months, respectively. P-values of 0.47, 0.47, and 0.24, respectively, were determined, which were not significant. Preoperative VA improvement was recorded in 92% of diabetics in Group B and 96% of nondiabetics in Group A. Two (8%) diabetic patients developed glaucoma and did not participate in the study further.
Conclusion: Remarkable improvement in VA was achieved in both Group A and B, but the Group A nondiabetics showed more improvement in best-corrected VA after Nd:YAG laser capsulotomy.

Keywords: diabetes, posterior capsule, capsule opacification, intraocular

A Letter to the Editor has been received and published for this article. 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]